Candriam Eqs L Onclgy Impct I GBP Cap

add to virtual portfolio
This fund can be held in
Trading AccountISAJISASIPP

Fund Info

  • Yield History-
  • 3 Year sharpe-
  • 3 Year alpha-
  • Distribution Typeaccumulation
  • BenchmarkMSCI World NR USD
  • Legal StructureSICAV
  • Fund Size (month end)SICAV
  • OCF1.00%
  • IA Sector-
  • Manager GroupCandriam
  • DomicileLuxembourg
  • ISINLU1864482515

Investment Strategy

The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) in order to respond to one of the serious long-term challenges of sustainable development. The sub-fund seeks to generate a return for investors while seeking to develop a socially responsible dimension: the fight against cancer. This sub-fund invests primarily in equities, and/or securities equivalent to equities, of companies throughout the world which are active in the health sector and which concentrate specifically on the research and development of cancer treatments.

Latest news

Currently there for this fund. Visit our news hub for other news .